$AME

RBC Capital raises Ametek stock price target on strong orders

RBC Capital raised its price target for Ametek Inc. (NYSE:AME) to $308 from $291, citing strong Q3 2026 results, including 17% organic order growth and a $5 billion acquisition. The stock trades at $250.64, with analysts expecting 14% upside. Ametek reported record backlog of $4.54 billion and raised its full-year outlook, with 9 analysts revising earnings upwards.

Original reporting
Published Nov 4, 2026, 2:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 2:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

The upgrade and earnings beat provide a fresh catalyst, likely prompting short‑term buying interest.

02

Market read

Analyst upgrade combined with strong earnings and a large acquisition creates a clear short‑term upside case for AME.

03

What to watch

Potential macro‑economic slowdown could temper order growth despite strong backlog.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

RBC Capital upgraded Ametek after reporting Q3 2026 results that beat estimates and announced a $5 billion acquisition.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

RBC Capital raised its price target on Ametek to $308, citing 17% organic order growth and a $5B acquisition, plus better-than-expected Q3 earnings.

Expected impact

likely upward pressure as the market prices in the higher target and earnings beat

Evidence & confidence

The new target implies ~14% upside from current price and reflects solid order growth and a large acquisition, which should attract buying.

Market effects

Positive signal for aerospace, defense, semiconductor and medical technology suppliers.

U.S. industrial and defense stocks may see modest gains.

Highlights continued demand in AI‑related hardware and defense modernization worldwide.

Counterpoint

If integration risks of the Indicor acquisition materialize, the upside could be limited.

Key entities

  • Ametek Inc.

    Industrial manufacturer with exposure to AI, defense and semiconductor infrastructure.

  • RBC Capital

    Equity research firm that raised the price target.

Related articles

$AMEHighAI 8/10

AMETEK (AME) Q3 2026 Earnings Call Transcript

AMETEK (AME) reported Q3 2026 earnings with organic sales up 10% and acquisitions adding 7 points, totaling $2.65B in orders. Record backlog reached $4.54B, up 27% YoY. Operating income hit $595M, up 20% YoY, with margins at 26.8%. EPS was $2.21, above guidance. EIG and EMG segments showed strong growth and margins. The company highlighted strategic acquisitions and market position.

$AMEHighAI 8/10

AMETEK Inc (AME) (Q3 2026) Earnings Call Highlights: Record Orders and Backlog Fuel Raised Guidance

AMETEK Inc. (AME) reported Q3 2026 earnings with record orders and backlog, raising guidance. CEO David Zapico highlighted strong organic growth in most segments, with Europe lagging. Interest expense rose due to Indicor acquisition, and inflation pressures persisted. The company expects strong visibility into 2027 due to a substantial backlog. M&A activity remains active, and Indicor's integration is progressing well.

$AMEHighAI 8/10

AMETEK Q3 Earnings Call Highlights

AMETEK reported Q3 sales growth of 16% for Electronic Instruments Group and 20% for Electromechanical Group. Full-year capital expenditures are expected to be $160M. The company raised its 2026 EPS guidance to $8.53-$8.57 and completed the acquisition of Indicor. AMETEK's debt increased to $6.7B, with net debt-to-EBITDA at 2.1x.

$AMEMedAI 9/10

AMETEK 3Q 2026: Revenue $2.22B, Net income $426.3M, EPS $1.85— 10-Q Summary

AMETEK reported Q3 2026 revenue of $2.22B, up 17.3% YoY, and net income of $426.3M, up 14.8%. EPS rose 15.6% to $1.85. Orders and backlog reached records at $2.65B and $4.54B, respectively. Sales growth was driven by organic expansion and acquisitions, with both segments showing gains. The company noted potential impacts from tariffs and geopolitical uncertainty.

$AMEHighAI 9/10

Why is Ametek stock surging today?

Ametek (AME) stock rose 4.0% to $251.62 after Q3 2026 earnings and revenue beat estimates by 4.7%. The company raised full-year EPS and revenue guidance, with orders and backlog reaching record highs. The acquisition of Indicor Instrumentation contributed significantly to revenue and EPS. The broader market showed modest gains, with the S&P 500 and Nasdaq up 0.6% and 1.1%, respectively.